Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,187,031
+$371,823 QoQ
Shares Held
40,366
+0.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#1,032
of 3,789 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HARBOUR INVESTMENTS, INC. holds $128,781,101 across 17 Drug Manufacturers - General names. MRK ranks #4 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
221,662 | $55,779,025 | |
| 2 | LLY |
ELI LILLY & Co
|
27,683 | $33,203,823 | |
| 3 | JNJ |
Johnson & Johnson
|
69,981 | $17,773,074 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
40,366 | $5,187,031 | |
| 5 | PFE |
Pfizer Inc
|
141,011 | $3,395,544 | |
| 6 | AMGN |
Amgen Inc
|
8,295 | $3,003,785 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
50,112 | $2,887,453 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
22,237 | $2,809,422 |
All Filings in MRK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,187,031 | 40,366 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,815,208 | 40,030 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,223,692 | 30,626 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,298,590 | 27,387 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,341,366 | 16,945 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $1,611,281 | 17,951 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,968,410 | 19,787 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,190,572 | 19,290 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,530,967 | 20,444 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $2,734,135 | 20,721 | Shares | Sole | 2024-07-22 | |
| 2023-12-31 | $2,306,318 | 21,155 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $2,029,762 | 19,716 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $2,244,450 | 19,451 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,207,166 | 20,746 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,317,856 | 20,891 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $1,358,629 | 15,776 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,438,297 | 15,776 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $1,099,170 | 14,342 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $2,236,850 | 29,781 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,183,703 | 28,079 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,103,247 | 27,283 | Shares | Sole | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||